Gene · 6118
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recognition and coacervation of G-quadruplexes by a multifunctional disordered region in RECQ4 helicase. | Nat Commun | 2023 | 37875529 | PubTator, text mining | PubMed |
| Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies: identification of RPA1 as a novel cancer predisposition candidate gene. | Front Oncol | 2023 | 37869077 | PubTator, text mining | PubMed |
| Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication. | Biomed Pharmacother | 2023 | 37864896 | PubTator, text mining | PubMed |
| Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma. | J Transl Med | 2023 | 37858134 | PubTator, text mining | PubMed |
| Hypoxia stabilizes SETDB1 to maintain genome stability. | Nucleic Acids Res | 2023 | 37850636 | PubTator, text mining | PubMed |
| Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium. | Mol Ther Methods Clin Dev | 2023 | 37841417 | PubTator, text mining | PubMed |
| The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks. | J Biol Chem | 2023 | 37838177 | PubTator, text mining | PubMed |
| Chemical Inhibition of RPA by HAMNO Alters Cell Cycle Dynamics by Impeding DNA Replication and G2-to-M Transition but Has Little Effect on the Radiation-Induced DNA Damage Response. | Int J Mol Sci | 2023 | 37834389 | PubTator, text mining | PubMed |
| Upregulated RPA2 in endometrial tissues of repeated implantation failure patients impairs the endometrial decidualization. | J Assist Reprod Genet | 2023 | 37831348 | PubTator, text mining | PubMed |
| ADAR1 links R-loop homeostasis to ATR activation in replication stress response. | Nucleic Acids Res | 2023 | 37831098 | PubTator, text mining | PubMed |
| Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability. | Cell | 2023 | 37827155 | PubTator, text mining | PubMed |
| Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1. | J Clin Invest | 2023 | 37815873 | PubTator, text mining | PubMed |
| Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker. | Front Oncol | 2023 | 37810966 | PubTator, text mining | PubMed |
| REPercussions: how geminiviruses recruit host factors for replication. | Front Microbiol | 2023 | 37799604 | PubTator, text mining | PubMed |
| FAM111A regulates replication origin activation and cell fitness. | Life Sci Alliance | 2023 | 37793778 | PubTator, text mining | PubMed |
| Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells. | Front Oncol | 2023 | 37781195 | PubTator, text mining | PubMed |
| DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. | Br J Cancer | 2023 | 37777579 | PubTator, text mining | PubMed |
| ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair. | J Exp Clin Cancer Res | 2023 | 37775817 | PubTator, text mining | PubMed |
| Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma. | Clin Cancer Res | 2023 | 37773632 | PubTator, text mining | PubMed |
| Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage. | Antioxidants (Basel) | 2023 | 37760080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6118/papers?page=8